| European Case Law Identifier: | ECLI:EP:BA:2011:T171009.20110412 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 12 April 2011 | ||||||||
| Case number: | T 1710/09 | ||||||||
| Petition for review: | R 0016/11 | ||||||||
| Application number: | 01201913.9 | ||||||||
| IPC class: | A61K 31/663 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Alendronate for use in the treatment of osteoporosis | ||||||||
| Applicant name: | Merck Sharp & Dohme Corp. | ||||||||
| Opponent name: | PLIVA, Farmaceutska Industrija Dionicko Drustvo + AWD.pharma GmbH & Co. KG STADA Arzneimittel AG Hexal AG + Sandoz AG Arrow International Ltd. betapharm Arzneimittel GmbH ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. Gedeon Richter Plc. Generics [UK] Ltd. et al STADA Arzneimittel GmbH "Interpharm" ProduktionsgmbH BIOGARAN Tecnimede, Sociedade Tecnico-Medicinal, S.A. ACTAVIS GROUP |
||||||||
| Board: | 3.3.02 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | All requests: added subject-matter (yes) | ||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t091710eu1.html
Date retrieved: 17 May 2021